These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28371346)

  • 21. Pyoderma gangrenosum and high titer serum anti-CCP2 antibodies.
    Das SK; Banerjee N; Khaskil S; Mukherjee SS
    JNMA J Nepal Med Assoc; 2012; 52(185):36-9. PubMed ID: 23279772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful Use of Adalimumab for Treating Pyoderma Gangrenosum with Ulcerative Colitis under Corticosteroid-tapering Conditions.
    Sagami S; Ueno Y; Tanaka S; Nagai K; Hayashi R; Chayama K
    Intern Med; 2015; 54(17):2167-72. PubMed ID: 26328641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disseminated skin necroses in a patient with multiple myeloma and monoclonal cryoglobulinaemia.
    Gambichler T; Schug T; Doerler M
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):e166-e167. PubMed ID: 30811662
    [No Abstract]   [Full Text] [Related]  

  • 24. Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib.
    Saldanha A; Veiga ME; Okazaki E; Rothschild C; Martinez G; Rocha V; Orsi FA; Villaca P
    J Thromb Thrombolysis; 2023 May; 55(4):770-774. PubMed ID: 37000318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pyoderma gangrenosum and Sweet syndrome: the prototypic neutrophilic dermatoses.
    Wallach D; Vignon-Pennamen MD
    Br J Dermatol; 2018 Mar; 178(3):595-602. PubMed ID: 26202386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pyoderma gangrenosum in hematologic malignancies: A systematic review.
    Montagnon CM; Fracica EA; Patel AA; Camilleri MJ; Murad MH; Dingli D; Wetter DA; Tolkachjov SN
    J Am Acad Dermatol; 2020 Jun; 82(6):1346-1359. PubMed ID: 31560977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
    Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
    Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A no scarring persistent skin lesion for 3 years pyoderma gangrenosum].
    Ndour MA; Sow D; Diedhiou D; Senghor F; Diembou M; Diouf M; Faye A; Diallo IM; Barrage AL; Kabou LM; Mbaye MN; Sarr A
    Pan Afr Med J; 2019; 32():198. PubMed ID: 31312310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study.
    Thomas KS; Ormerod AD; Craig FE; Greenlaw N; Norrie J; Mitchell E; Mason JM; Johnston GA; Wahie S; Williams HC;
    J Am Acad Dermatol; 2016 Nov; 75(5):940-949. PubMed ID: 27502313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyoderma gangrenosum due to lenalidomide use for multiple myeloma.
    Dasanu CA; Bockorny B; Alexandrescu DT
    J Oncol Pharm Pract; 2015 Dec; 21(6):471-3. PubMed ID: 24986794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [IgA pemphigus accompanying multiple myeloma has disappeared following the treatment with bortezomib (Velcade), cyclophosphamide and dexamethasone. Case study and literature review].
    Adam Z; Feit J; Krejcí M; Pour L; Vasků V; Cermáková Z; Mayer J; Hájek R
    Vnitr Lek; 2009 Oct; 55(10):981-90. PubMed ID: 19947244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyoderma gangrenosum complicating bilateral mammaplasty.
    Gudi VS; Julian C; Bowers PW
    Br J Plast Surg; 2000 Jul; 53(5):440-1. PubMed ID: 10876287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 1 Cryoglobulinemic Vasculitis Due to Monoclonal Gammopathy of Undetermined Significance Successfully Treated by Bortezomib Plus Dexamethasone.
    Kikuchi R; Onozawa M; Nagai J; Okada S; Hasegawa Y; Ohigashi H; Mitamura S; Maeda T; Takakuwa E; Fujieda Y; Goto H; Hashimoto D; Matsuno Y; Teshima T
    Intern Med; 2024 Feb; 63(4):541-545. PubMed ID: 37316269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter: Treatment-resistant pyoderma gangrenosum.
    Kosari P; Feldman SR
    Dermatol Online J; 2012 Apr; 18(4):8. PubMed ID: 22559023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of Light Chain Proximal Tubulopathy without Crystals in IgGλ-type Monoclonal Gammopathy of Undetermined Significance Using Bortezomib and Dexamethasone.
    Tsuyuki T; Uramatsu T; Shimizu M; Ishi T; Tsuji K; Nakashima J; Katafuchi E; Nakayama T; Uesugi N; Muta K; Nishino T
    Intern Med; 2024 Mar; 63(5):693-698. PubMed ID: 37438138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophilic dermatosis resembling pyoderma gangrenosum in a dog with polyarthritis.
    Bardagí M; Lloret A; Fondati A; Ferrer L
    J Small Anim Pract; 2007 Apr; 48(4):229-32. PubMed ID: 17381769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pyoderma Gangrenosum: A Current Problem as Much as an Unknown One.
    Vallini V; Andreini R; Bonadio A
    Int J Low Extrem Wounds; 2017 Sep; 16(3):191-201. PubMed ID: 28915774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between neutrophilic dermatosis of the dorsal hands and sweet syndrome: report of 9 cases and comparison to atypical pyoderma gangrenosum.
    Walling HW; Snipes CJ; Gerami P; Piette WW
    Arch Dermatol; 2006 Jan; 142(1):57-63. PubMed ID: 16415387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyoderma gangrenosum and monoclonal gammopathy.
    Powell FC; Schroeter AL; Su WP; Perry HO
    Arch Dermatol; 1983 Jun; 119(6):468-72. PubMed ID: 6859886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of pyoderma gangrenosum with topical factor XIII.
    Hoetzenecker W; Guenova E; Mitev V; Schanz S; Ulmer A; Fierlbeck G
    Eur J Dermatol; 2013; 23(5):653-7. PubMed ID: 24135449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.